146 related articles for article (PubMed ID: 36167736)
1. Rehospitalization of Patients with Advanced Heart Failure Receiving Continuous, Palliative Dobutamine or Milrinone.
Eaton RE; Kissling KT; Haas GJ; McLaughlin EM; Pickworth KK
Am J Cardiol; 2022 Dec; 184():80-89. PubMed ID: 36167736
[TBL] [Abstract][Full Text] [Related]
2. Palliative Inotropes in Advanced Heart Failure: Comparing Outcomes Between Milrinone and Dobutamine.
Sami F; Acharya P; Noonan G; Maurides S; Al-Masry AA; Bajwa S; Parimi N; Boda I; Tran C; Goyal A; Mastoris I; Dalia T; Sauer A; Bakel AV; Shah Z
J Card Fail; 2022 Dec; 28(12):1683-1691. PubMed ID: 36122816
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock.
Biswas S; Malik AH; Bandyopadhyay D; Gupta R; Goel A; Briasoulis A; Fonarow GC; Lanier GM; Naidu SS
Curr Probl Cardiol; 2023 Aug; 48(8):101245. PubMed ID: 35545181
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Positive Inotropic Agents in the Management of Acute Decompensated Heart Failure.
Kelly J; Cheng J; Malloy R; Lupi K
J Cardiovasc Pharmacol; 2020 May; 75(5):455-459. PubMed ID: 32091426
[TBL] [Abstract][Full Text] [Related]
5. Effect of Inpatient Dobutamine versus Milrinone on Out-of-Hospital Mortality in Patients with Acute Decompensated Heart Failure.
King JB; Shah RU; Sainski-Nguyen A; Biskupiak J; Munger MA; Bress AP
Pharmacotherapy; 2017 Jun; 37(6):662-672. PubMed ID: 28475215
[TBL] [Abstract][Full Text] [Related]
6. Survival With Continuous Outpatient Intravenous Inotrope Therapy in the Modern Era.
Mody BP; Khan MH; Zaid S; Ahn C; Lloji A; Aronow WS; Gupta CA; Levine A; Gass AL; Cooper HA; Lanier GM
Am J Ther; 2020 Oct; 28(6):e621-e630. PubMed ID: 33021537
[TBL] [Abstract][Full Text] [Related]
7. Need for hospice and palliative care services in patients with end-stage heart failure treated with intermittent infusion of inotropes.
López-Candales AL; Carron C; Schwartz J
Clin Cardiol; 2004 Jan; 27(1):23-8. PubMed ID: 14743852
[TBL] [Abstract][Full Text] [Related]
8. Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure.
Gorodeski EZ; Chu EC; Reese JR; Shishehbor MH; Hsich E; Starling RC
Circ Heart Fail; 2009 Jul; 2(4):320-4. PubMed ID: 19808355
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative milrinone versus dobutamine in cardiac surgery patients: a retrospective cohort study on mortality.
Nielsen DV; Torp-Pedersen C; Skals RK; Gerds TA; Karaliunaite Z; Jakobsen CJ
Crit Care; 2018 Feb; 22(1):51. PubMed ID: 29482650
[TBL] [Abstract][Full Text] [Related]
10. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
[TBL] [Abstract][Full Text] [Related]
11. Inotropic therapy for right ventricular failure in newborn piglets: effect on contractility, hemodynamics, and interventricular interaction.
Hyldebrandt JA; Frederiksen CA; Heiberg J; Rothmann S; Redington AN; Schmidt MR; Ravn HB
Pediatr Crit Care Med; 2014 Sep; 15(7):e327-33. PubMed ID: 25080150
[TBL] [Abstract][Full Text] [Related]
12. Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.
Aranda JM; Schofield RS; Pauly DF; Cleeton TS; Walker TC; Monroe VS; Leach D; Lopez LM; Hill JA
Am Heart J; 2003 Feb; 145(2):324-9. PubMed ID: 12595851
[TBL] [Abstract][Full Text] [Related]
13. Inotropes and cardiorenal syndrome in acute heart failure - A retrospective comparative analysis.
Madeira M; Caetano F; Almeida I; Fernandes A; Reis L; Costa M; Gonçalves L
Rev Port Cardiol; 2017 Sep; 36(9):619-625. PubMed ID: 28826934
[TBL] [Abstract][Full Text] [Related]
14. Continuous Cardiac Inotropes in Patients With End-Stage Heart Failure: An Evolving Experience.
Malotte K; Saguros A; Groninger H
J Pain Symptom Manage; 2018 Jan; 55(1):159-163. PubMed ID: 29030210
[TBL] [Abstract][Full Text] [Related]
15. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
Barraud D; Faivre V; Damy T; Welschbillig S; Gayat E; Heymes C; Payen D; Shah AM; Mebazaa A
Crit Care Med; 2007 May; 35(5):1376-82. PubMed ID: 17414729
[TBL] [Abstract][Full Text] [Related]
16. The effect of dobutamine vs milrinone in sepsis: A big data, real-world study.
Zhu Y; Yin H; Zhang R; Ye X; Wei J
Int J Clin Pract; 2021 Nov; 75(11):e14689. PubMed ID: 34331721
[TBL] [Abstract][Full Text] [Related]
17. Continuous Inotrope Therapy in Hospice Care: A Case Series.
Patel K; D'Souza A; Groninger H
Am J Hosp Palliat Care; 2019 Jul; 36(7):660-663. PubMed ID: 30630349
[TBL] [Abstract][Full Text] [Related]
18. Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact.
Yamani MH; Haji SA; Starling RC; Kelly L; Albert N; Knack DL; Young JB
Am Heart J; 2001 Dec; 142(6):998-1002. PubMed ID: 11717603
[TBL] [Abstract][Full Text] [Related]
19. Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure.
Rodenas-Alesina E; Luis Scolari F; Wang VN; Brahmbhatt DH; Mihajlovic V; Fung NL; Otsuki M; Billia F; Overgaard CB; Luk A
ESC Heart Fail; 2023 Aug; 10(4):2577-2587. PubMed ID: 37322827
[TBL] [Abstract][Full Text] [Related]
20. Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone.
Earl GL; Verbos-Kazanas MA; Fitzpatrick JM; Narula J
Pharmacotherapy; 2007 May; 27(5):697-706. PubMed ID: 17461705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
